Publication Venue For

  • Immunotherapy approaches for the treatment of diffuse midline gliomas.  11. 2022
  • Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen.  9. 2020
  • A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition.  8. 2019
  • Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer.  8. 2019
  • Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials.  8. 2019
  • Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escape..  8:e1568809. 2019
  • Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor.  8. 2019
  • The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder.  5. 2016
  • TAM macrophages promote growth and metastasis within the cancer ecosystem.  3. 2014
  • The dual targeting of immunosuppressive cells and oxidants promotes effector and memory T-cell functions against lung cancer.  3. 2014
  • A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma.  2:1-2. 2013
  • Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease.  2. 2013
  • Role of plasmacytoid dendritic cells in breast cancer bone dissemination.  2. 2013
  • International Standard Serial Number (issn)

  • 2162-4011
  • Electronic International Standard Serial Number (eissn)

  • 2162-402X